Australia TGA ARTG record

VENOVO Venous Stent System - Iliofemoral vein stent

Australia TGA ARTG Registered Device · Bard Australia Pty Ltd · Angiomed GmbH & Co Medizintechnik KG · Class III · Started June 01, 2023

Good Name: Bard Australia Pty Ltd - VENOVO Venous Stent System - Iliofemoral vein stent

Device classification

Risk Class: Class III
Product Type: Medical device system
ARTG Category: General

Registration information

Start Date: June 01, 2023
Effective Date: June 01, 2023

Sponsor

Name: Bard Australia Pty Ltd

Manufacturer

Name: Angiomed GmbH & Co Medizintechnik KG
Country: Germany
Address: Wachhausstrasse 6, KARLSRUHE, 76227

Intended purpose

The Venovo Venous Stent System is indicated for the treatment of symptomatic Iliofemoral venous outflow obstruction.

About this record

Access comprehensive regulatory information for VENOVO Venous Stent System - Iliofemoral vein stent in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class III is sponsored by Bard Australia Pty Ltd, manufactured by Angiomed GmbH & Co Medizintechnik KG in Germany. The device registration started on June 01, 2023.

This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.